The U.S. Army Medical Research Acquisition Activity and the U.S. Army Medical Research Institute of Infectious Diseases is seeking research services to develop treatments for arenaviruses, according to a Jan. 27 release.
Found around the globe, arenaviruses include many fevers and hemorrhagic fevers that have reservoir animals that consist of various species of rodents and bats. These viruses are largely spread through contact with excretions from an infected animal, and according to the Centers for Disease Control's common infection pathways are in homes and agricultural facilities.
Treatments for these kinds of viruses are limited as no vaccine exists and only one viable drug treatment has been approved. Ribavirin, a nucleoside analogue, has been effective in the early stages of infection, but it has risks of toxicity.
Army officials expect to award one contract based on the solicitation that will be released Wednesday on both the U.S. Army website (under acquisitions) and on the General Services Administration site (under the Federal Business Opportunities site).
The posting lists contract specialist Samantha Connors as the point of contact. She can be reached at firstname.lastname@example.org.